Expanding the Repertoire of Modified Vaccinia Ankara-Based Vaccine Vectors via Genetic Complementation Strategies

• David A. Garber ,

  * E-mail: david.garber@emory.edu

  Affiliations Emory Vaccine Center, Emory University, Atlanta, Georgia, United States of America, Department of Medicine, Emory University, Atlanta, Georgia, United States of America

  ⨯
• Leigh A. O'Mara,

  Affiliation Emory Vaccine Center, Emory University, Atlanta, Georgia, United States of America

  ⨯
• Jun Zhao,

  Affiliation Emory Vaccine Center, Emory University, Atlanta, Georgia, United States of America

  ⨯
• Sailaja Gangadhara,

  Affiliation Emory Vaccine Center, Emory University, Atlanta, Georgia, United States of America

  ⨯
• InChul An,

  Affiliation Emory Vaccine Center, Emory University, Atlanta, Georgia, United States of America

  ⨯
• Mark B. Feinberg

  Current address: Merck Vaccines and Infectious Diseases, Merck & Co. Inc., West Point, Pennsylvania, United States of America

  Affiliations Emory Vaccine Center, Emory University, Atlanta, Georgia, United States of America, Department of Medicine, Emory University, Atlanta, Georgia, United States of America, Department of Microbiology and Immunology, Emory University, Atlanta, Georgia, United States of America

  ⨯